MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
- Country
- Germany
- Type
- Beneficiary
- Website
- www.merckgroup.com
- Grants received
- 38
Funding record
- 38 grants on record
- €4,839,119.53 awarded in total
- 2012–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
30 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- BAYER AKTIENGESELLSCHAFT
- JANSSEN PHARMACEUTICA NV
- NOVARTIS PHARMA AG
- ASTRAZENECA AB
- ABBVIE INC
- BOEHRINGER INGELHEIM INTERNATIONALGMBH
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Calls from this organisation
No published calls from this organisation.
Grants received
- Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing
- Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- - addressing the challenges of high-performance solution-processed OLEDs using sustainable materials
- BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe
- Building a reproducible single-cell experimental workflow to capture tumour cell persistence
- Real World Handling of Protein Drugs - Exploration, Evaluation and Education
- Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
- HIGH PERFORMING AND SAFE SOLVENT DERIVED FROM CELLULOSIC FEEDSTOCKS
- Corona Accelerated R&D in Europe
- Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
- Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials
- MachinE Learning Ledger Orchestration for Drug DiscoverY
- Appearance Printing - European Advanced Research School
- Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.